|
NDUFB7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.685900E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.636000E-02 |
| Normal-vs-Stage2 |
4.358000E-01 |
| Normal-vs-Stage3 |
1.763590E-02 |
| Normal-vs-Stage4 |
8.593900E-02 |
| Stage1-vs-Stage2 |
1.999170E-01 |
| Stage1-vs-Stage3 |
6.819400E-01 |
| Stage1-vs-Stage4 |
9.542800E-01 |
| Stage2-vs-Stage3 |
1.707440E-01 |
| Stage2-vs-Stage4 |
2.101200E-01 |
| Stage3-vs-Stage4 |
6.858000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.574400E-02 |
| Normal-vs-AfricanAmerican |
2.804000E-01 |
| Normal-vs-Asian |
1.109950E-01 |
| Caucasian-vs-AfricanAmerican |
1.629710E-02 |
| Caucasian-vs-Asian |
4.430000E-01 |
| AfricanAmerican-vs-Asian |
1.276220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.808970E-01 |
| Normal-vs-Female |
8.634300E-02 |
| Male-vs-Female |
8.462600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.318800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.488010E-02 |
| Normal-vs-Age(61-80Yrs) |
6.843600E-02 |
| Normal-vs-Age(81-100Yrs) |
3.826400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.596800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.823400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.094600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.942000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.696200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.903200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.213600E-01 |
| Normal-vs-Grade 2 |
2.513400E-01 |
| Normal-vs-Grade 3 |
5.865800E-02 |
| Normal-vs-Grade 4 |
5.527900E-02 |
| Grade 1-vs-Grade 2 |
7.289000E-01 |
| Grade 1-vs-Grade 3 |
8.193400E-01 |
| Grade 1-vs-Grade 4 |
9.601800E-01 |
| Grade 2-vs-Grade 3 |
8.640000E-01 |
| Grade 2-vs-Grade 4 |
5.785200E-01 |
| Grade 3-vs-Grade 4 |
5.717400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.076100E-03 |
| Normal-vs-ccB subtype |
3.537400E-03 |
| ccA subtype-vs-ccB subtype |
8.887400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.053900E-02 |
| Normal-vs-N1 |
8.600200E-01 |
| N0-vs-N1 |
5.886400E-01 |
|
|
